Works matching IS 17574676 AND DT 2023 AND VI 15 AND IP 8
Results: 8
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 8, p. 1, doi. 10.15252/emmm.202318014
- By:
- Publication type:
- Article
MSTO1 is a cytoplasmic pro‐mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 8, p. 1, doi. 10.15252/emmm.202317911
- By:
- Publication type:
- Article
ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 8, p. 1, doi. 10.15252/emmm.202217313
- By:
- Publication type:
- Article
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα<sup>+</sup> breast cancer.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 8, p. 1, doi. 10.15252/emmm.202217248
- By:
- Publication type:
- Article
Maternal diet and gut microbiome composition modulate early‐life immune development.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 8, p. 1, doi. 10.15252/emmm.202217241
- By:
- Publication type:
- Article
Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 8, p. 1, doi. 10.15252/emmm.202216845
- By:
- Publication type:
- Article
Answer to Gerber et al. "Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy".
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 8, p. 1, doi. 10.15252/emmm.202216251
- By:
- Publication type:
- Article
Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 8, p. 1, doi. 10.15252/emmm.202216090
- By:
- Publication type:
- Article